The Drew Weissman Lab

The Drew Weissman Lab

@drewweissmanlab.bsky.social

Bringing mRNA therapeutics to the world. University of Pennsylvania https://www.med.upenn.edu/weissmanlab/

205 Followers 77 Following 30 Posts Joined Dec 2024
1 month ago
Post image

Weissman Lab wishes everyone a Happy International Day of Women and Girls in Science! #InternationalDayofWomenandGirlsinScience

2 1 0 0
1 month ago

Cedar fever cure? Researchers developing vaccine for severe allergies
@jilianmelamed.bsky.social
www.kxan.com/news/science...

0 0 0 0
3 months ago
Preview
Welcome! You are invited to join a webinar: RNA Collaborative - NCI RNA Biology Initiative & Penn Institute for RNA Innovation. After registering, you will receive a confirmation email about joining t... Featuring: “Mechanism of mRNA decay inhibition by a bacterial pathogen effector" Dr. Eugene Valkov Stadtman Investigator, RNA Biology Laboratory, Center for Cancer Research, National Cancer Institut...

📣Today @ 4pm: RNA Collaborative - NCI RNA Biology Initiative & Penn Institute for RNA Innovation, featuring BMB graduate student Rachel Braun “Selective decay of interferon mRNAs controls antiviral immunity and innate memory"
us02web.zoom.us/webinar/regi...

2 0 0 0
4 months ago
Preview
16th Scientific Day: CRCHUM welcomes RNA pioneer On October 22, nearly 450 people attended the CRCHUM’s 16th Scientific Day devoted to RNA biology and its clinical applications. Researchers, members of the student and university community, and partn...

www.chumontreal.qc.ca/en/actualite...

0 0 0 0
4 months ago
Preview
Anionic lipids modulate mRNA-lipid nanoparticle immunogenicity and confer protection in a mouse model of multiple sclerosis The modularity of mRNA-lipid nanoparticle (mRNA-LNP) platforms has enabled their rapid adaptation from infectious disease vaccines to emerging applications in immune-mediated disorders. However, exten...

🎉Our newest pre-print is now online on bioRxiv! Anionic lipids modulate mRNA-lipid nanoparticle immunogenicity and confer protection in a mouse model of multiple sclerosis
@jilianmelamed.bsky.social www.biorxiv.org/content/10.1...

1 0 0 0
5 months ago
New research seeks an mRNA therapy for heavy menstrual bleeding | Penn Medicine Every minute in the U.S., a woman needs a blood transfusion due to her period. Kathleen O’Neill, MD, is working to develop a novel therapy to protect women.

www.pennmedicine.org/news/new-res...

3 1 0 0
7 months ago
Post image

This week we'll be at the CRS 2025 Annual Meeting & Expo!
#CRS2025

1 0 0 0
8 months ago
Preview
Red Ribbon Connect links Penn with HIV/AIDS researchers worldwide | Penn Today Organized by a recent Penn alum on the Community Advisory Board of the Penn Center for AIDS Research, the newly launched Red Ribbon Connect program entails a monthly virtual exchange for HIV/AIDS rese...

Red Ribbon Connect links Penn with HIV/AIDS researchers worldwide bit.ly/4ksSslO

1 0 0 0
9 months ago
Preview
An Il12 mRNA-LNP adjuvant enhances mRNA vaccine–induced CD8 T cell responses IL-12 is dispensable for CD8 T cell responses to mRNA vaccination, but an Il12 mRNA-LNP enhances CD8 T cell memory and protection.

How adding mRNA to code for interleukin-12 markedly increased T cell immune response which could be used for vaccines vs infectious diseases and cancer @sciimmunology.bsky.social
www.science.org/doi/10.1126/...

366 85 5 5
8 months ago
Preview
Researchers crack the code of body’s ancient immune defense | Penn Today A collaborative team from Penn Medicine and Penn Engineering have  unraveled the mathematics of a 500-million-year-old protein network that “decides” which foreign materials are friend or foe.

Researchers crack the code of body’s ancient immune defense @pennengineering.bsky.social‬ @upenn.bsky.social‬

bit.ly/4n7qY7F

1 0 0 0
8 months ago
Preview
Why Does the Phrase “mRNA” Rip Americans Apart? We Chat w Nobel-Prize Winning Scientist Drew Weissman Podcast Episode · Why Should I Trust You? · 06/12/2025 · 1h 5m

podcasts.apple.com/us/podcast/w...

1 1 0 0
8 months ago
Preview
Harnessing the Electron-Withdrawing Inductive Effect of One-Component Ionizable Amphiphilic Janus Dendrimers Unveils Cation−π Interactions and Their Important Roles to Targeted mRNA Delivery It is expected that current medicine will be complemented or even replaced with genetic nanomedicine, which relies on the targeted delivery of nucleic acids. Delivery of mRNA is accomplished using viral and synthetic four-component vectors which deliver the nucleic acid predominantly to the liver. Our laboratories elaborated a one-component ionizable amphiphilic Janus dendrimer (IAJD) which targets the delivery of mRNA and, therefore, is complementary to viral and synthetic vectors. Here we report the study of a library of IAJDs containing derivatives of the natural gallic acid (GA) as branched hydrophobic domain and two ionizable amines connected via four linker length. The linker length mediates an electron-withdrawing inductive effect, which changes the pKa of the IAJDs. The same pKa trend was observed in a previously reported pentaerythritol (PE)-library, which has structures identical to those of the GA-library except that it does not contain the aromatic ring. Unpredictable, the GA-library of IAJDs has consistently higher pKa values than the PE-library, although the linker length-pKa dependence follows the same trend in both libraries. This trend indicates an unexpected cation−π interaction which explains some advantages of GA-IAJDs, including the 109 p/s total luciferase activity reported here.

Harnessing the Electron-Withdrawing Inductive Effect of One-Component Ionizable Amphiphilic Janus Dendrimers Unveils Cation−π Interactions and Their Important Roles to Targeted mRNA Delivery | Journal of the American Chemical Society pubs.acs.org/doi/10.1021/...

2 0 0 0
9 months ago
Preview
An Il12 mRNA-LNP adjuvant enhances mRNA vaccine–induced CD8 T cell responses IL-12 is dispensable for CD8 T cell responses to mRNA vaccination, but an Il12 mRNA-LNP enhances CD8 T cell memory and protection.

We're not the first to use IL-12 as an adjuvant - but having worked on IL-12 for >30 years this was still a surprise at how much this study taught us about mRNA vaccines and their utility. Here are two others below:
www.science.org/doi/10.1126/...
@cytokinesociety.bsky.social

28 7 3 1
9 months ago
Post image

Big congrats to our superstar, Jaclynn Meshanni, for winning an ATS abstract scholarship! 🌟 So proud of your hard work.

P.S. She also throws a great craft gift exchange! 😉

@atscommunity.bsky.social

2 0 0 0
9 months ago
Preview
Cancer-fighting immune cells could soon be engineered inside our bodies Manufacturing CAR T cells in the laboratory is expensive and time-consuming. An in vivo approach could get the powerful therapy to more people.

Cancer-fighting immune cells could soon be engineered inside our bodies www.nature.com/articles/d41...

0 0 0 0
10 months ago
Preview
Expanding Role of mRNA Platform with Nobel Laureate Dr. Drew Weissman - Curetalks We are excited to welcome Nobel Laureate Dr. Drew Weissman from the University of Pennsylvania yet again on CureTalks.  Dr.Weissman’s groundbreaking research in messenger RNA (mRNA) technology earned ...

Expanding Role of mRNA Platform with Nobel Laureate Dr. Drew Weissman curetalks.com/expanding-ro... via

0 0 0 0
10 months ago
Preview
Scientists Hail This Medical Breakthrough. A Political Storm Could Cripple It.

Scientists Hail This Medical Breakthrough. A Political Storm Could Cripple It. www.nytimes.com/2025/05/08/u...

1 1 0 0
10 months ago
Post image

The 2025 Bioengineering Graduate Research Symposium is next Friday! Lab members 𝗝𝗲𝗻𝗻𝗮 𝗠𝘂𝘀𝗰𝗮𝘁-𝗥𝗶𝘃𝗲𝗿𝗮 and 𝗠𝗶𝗰𝗵𝗮𝗲𝗹 𝗞𝗲𝗴𝗲𝗹 will be presenting posters and keynote speaker is Drew Weissman! #PennBioengineering

2 1 0 0
10 months ago
Post image

The 2025 Bioengineering Graduate Research Symposium is next Friday! Lab members 𝗝𝗲𝗻𝗻𝗮 𝗠𝘂𝘀𝗰𝗮𝘁-𝗥𝗶𝘃𝗲𝗿𝗮 and 𝗠𝗶𝗰𝗵𝗮𝗲𝗹 𝗞𝗲𝗴𝗲𝗹 will be presenting posters and keynote speaker is Drew Weissman! #PennBioengineering

2 1 0 0
10 months ago
Post image

Congratulations to Katalin Karikó (@PennNSG), Virginia Lee (@pennpathlabmed.bsky.social), @ejohnwherry.bsky.social (@PennSysPharmATT) & Mark Devlin (@physatpenn) on their election to @nasonline.org! tinyurl.com/5eehdtms

16 7 0 1
10 months ago
YouTube
Join Us at Cellicon Valley '25: The Future of Cell and Gene Therapies YouTube video by Penn Medicine

Join Us at Cellicon Valley '25: The Future of Cell and Gene Therapies
youtu.be/OJzW-XknmHA?...

0 0 0 0
11 months ago
Post image

Today at 3pm!

0 0 0 0
11 months ago
Preview
SCIMaP - Impacts of Federal Cuts to Science and Medical Research Developed by an interdisciplinary research team, this website shows how funding cuts reduce economic activity and employment nationwide

See national impact of federal health research cuts scienceimpacts.org

1 0 0 0
11 months ago
Preview
Making Every Penny Count: Kinase Signaling Transduction, Copper Homeostasis, & Nutrient Sensing I am the Harrison McCrea Dickson, MD, and Clifford C. Baker, MD Presidential Associate Professor of Cancer Biology at the University of Pennsylvania P…

Several months ago, I was honored to be invited by JMB Editor-in-Chief Mike Summers to write a Perspective for the Pioneers in Molecular Biology special issue. It was a chance to reflect on the journey that led me here. You can read the pieces here: tinyurl.com/2pb967u9 & tinyurl.com/kkwfynt2

31 11 2 0
11 months ago
Preview
The Mütter Museum presents Trusted Messengers: Community, Confidence,… A new special exhibition at the Mütter Museum marks five years since the first Covid shutdowns, honoring the healthcare workers, researchers, and…

www.broadstreetreview.com/reviews/the-...

0 0 0 0
11 months ago
Post image

NIH cuts that hit a breakthrough in cancer treatment for a refractory, metastatic GI cancer
Front page @washingtonpost.com
Gift link wapo.st/4j8Hwd1 @carolynyjohnson.bsky.social
@naturemedicine.bsky.social
www.nature.com/articles/s41...

202 81 6 8
11 months ago
Post image
0 0 0 0
11 months ago
Post image

RNADay@Penn 2025 starts today at 2pm!

0 0 0 0
11 months ago
Don't kill the messenger: The potential of mRNA therapies Messenger ribonucleic acid (mRNA)- based therapies represent a new era in modern medicine. Synthetic mRNA can encode and express any protein. The fast, effective, and temporary nature of mRNA-encoded proteins makes them attractive tools to address several conditions.

www.abcam.com/en-us/storie...

2 0 0 0
11 months ago
Preview
Q&A: Nobel Prize-winning researcher and BU grad discusses vaccine development, vaccine hesitancy, and preparing for another pandemic Weissman was jointly awarded the 2023 Nobel Prize in Medicine with Katalin Karikó for discoveries which made COVID-19 vaccines possible.

www.boston.com/news/health/... @boston.com

0 0 0 0